A
AccuVein
AccuVein develops products that aid in the visualization of peripheral vasculature
About AccuVein
AccuVein Inc. is a pioneering company in the medical technology sector, specializing in vein visualization solutions. The company operates in the healthcare market, serving a diverse range of clients including hospitals, clinics, and individual healthcare practitioners. AccuVein's core product is a handheld device that projects a map of veins directly onto the skin, significantly improving the success rate of intravenous (IV) insertions and blood draws. This technology is particularly beneficial for patients with difficult venous access, such as children and individuals with darker skin tones. The company's business model revolves around the sale and rental of its vein visualization devices, along with supplementary products like stands and protective covers. Revenue is generated through direct sales, rentals, and ongoing service agreements. AccuVein's technology is endorsed by the Infusion Nurses Society and is used by 8 out of 10 vein visualization users, underscoring its market leadership. The company also offers a short-term rental program to support urgent medical needs, such as those arising from the COVID-19 pandemic.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2006
- Headquarters
- New York City, United States
- Employees
- 104
- Open positions
- None listed
- Dealroom signal
- 40.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Patient Care, Core AI, Hard Tech, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Computer Vision
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Feb 2023 | $5.3M | $21M | Undisclosed | — |
| LATE VCOther financing | Apr 2022 | $17M | $69M | Undisclosed | — |
Growth signals
Latest recorded traffic for AccuVein is 19K monthly website visits, up 35.7% over the last three months. AccuVein's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series A2 investors entered at this stage
Bessemer Venture Partners
MVM Life Science Partners
Series B and later3 investors entered at this stage
Horizon Technology Finance Corporation
Kemmons Wilson Companies- RMRiver Street Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AccuVein on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AccuVein’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.